LGND - Ligand Pharmaceuticals Non-GAAP EPS of $1.02 beats by $0.40 revenue of $32.87M beats by $5.65M
2023-11-08 16:43:55 ET
More on Ligand Pharmaceuticals
- Ligand: Nothing Exciting Stands Out
- Ligand Pharmaceuticals Q3 2023 Earnings Preview
- Ligand Pharmaceuticals acquires 13% of soticlestat royalties from Ovid Therapeutics for $30M
- Seeking Alpha’s Quant Rating on Ligand Pharmaceuticals
- Historical earnings data for Ligand Pharmaceuticals
For further details see:
Ligand Pharmaceuticals Non-GAAP EPS of $1.02 beats by $0.40, revenue of $32.87M beats by $5.65M